Haiping Yao

发表

LincRNA‐EPS impairs host antiviral immunity by antagonizing viral RNA–PKR interaction

Zhengrong Chen, Shengchuan Chen, Ping Xu, 2022, EMBO reports.

Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.

Xiaoguang Chen, R. Cao, Jie-Xing Zhou, 2015, Bioorganic & medicinal chemistry.

A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers

Jie Zhou, T. Du, Xiaoguang Chen, 2022, Frontiers in Pharmacology.

Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.

Xiaoguang Chen, R. Cao, Jie-Xing Zhou, 2018, Organic & biomolecular chemistry.

LincRNA‐EPS alleviates severe acute pancreatitis by suppressing HMGB1‐triggered inflammation in pancreatic macrophages

Mengtao Zhou, Yanghua Qin, Qiyu Zhang, 2021, Immunology.

STING-mediated degradation of IFI16 negatively regulates apoptosis by inhibiting p53 phosphorylation at serine 392

Fan Zhang, Lifen Xie, Yanghua Qin, 2021, The Journal of biological chemistry.

IFI16 Isoforms with Cytoplasmic and Nuclear Locations Play Differential Roles in Recognizing Invaded DNA Viruses

Lifen Xie, Zhengrong Chen, Yanghua Qin, 2021, The Journal of Immunology.

Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis.

Bailing Xu, M. Ji, Xiaoyu Wang, 2023, Journal of medicinal chemistry.

Housekeeping U1 snRNA facilitates antiviral innate immunity by promoting TRIM25-mediated RIG-I activation.

Jianfeng Dai, Jingfei Zhu, Zigang Qiao, 2024, Cell reports.